New Intra-Day Highs for the year for the S&P 500 and the Dow Industrial's stocks

continue the year-end rally.

That is the scorecard on Wall Street, but the action is just getting started.

Welcome to Closing Bell overtime.

I'm Morgan Brennan with John Fort.

And coming up on today's show, we're going to speak exclusively

to the CEO of CRISPR Therapeutics

following the FDA's first of its kind approval of the company's gene therapy in this

case to treat sickle cell disease that stock has been selling off the last two days

on the back of that news.

Plus Oracle is gearing up for earnings this hour

with the $300 billion software giant

handily outperforming the market this year.

We'll bring you those numbers as soon as they cross.

We begin though with the market and greet across the screen as we kick off a crucial

week on Wall Street with the CPI print tomorrow, that inflation gauge, final Fed decision

of the year, the day after that on Wednesday.

Mike Santoli, joining us now from the New York Stock Exchange, Mike, a lot of green

but communication services, the one sector that said it out today and to an extreme it was down a full percent.

Yeah so the alphabet and Meta were big decliners in fact all the big NASDAQ stocks

were on the downside. It's reflection of this continued, you know, money flowing out of the big year-to-date winners into the rest of the market. There also has been a NASDAQ index change that I can talk about in a bit that actually has to do with that too.

But the rest of the market is seems like it's in a pretty benign state.

...